{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T04:46:32Z","timestamp":1784609192485,"version":"3.55.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004085","name":"Ministry of Education, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2018R1D1A3B07046990"],"award-info":[{"award-number":["NRF-2018R1D1A3B07046990"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.bmc.2021.116550","type":"journal-article","created":{"date-parts":[[2021,12,4]],"date-time":"2021-12-04T10:34:49Z","timestamp":1638614089000},"page":"116550","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Synthesis and biological evaluation of quinolone derivatives as transthyretin amyloidogenesis inhibitors and fluorescence sensors"],"prefix":"10.1016","volume":"53","author":[{"given":"Ah","family":"Reum Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun","family":"Hee Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Woo Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seul","family":"Ki Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan-yeong","family":"Ohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung","family":"Jean Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nam","family":"Sook Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8046-6836","authenticated-orcid":false,"given":"Tae-Sung","family":"Koo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki","family":"Bum Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungwook","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bmc.2021.116550_b0005","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrn1007","article-title":"Unfolding the role of protein misfolding in neurodegenerative diseases","volume":"4","author":"Soto","year":"2003","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.bmc.2021.116550_b0010","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1146\/annurev.med.51.1.543","article-title":"The genetics of the amyloidoses","volume":"51","author":"Buxbaum","year":"2000","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.bmc.2021.116550_b0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1146\/annurev-biochem-061516-045115","article-title":"Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade","volume":"86","author":"Chiti","year":"2017","journal-title":"Annu Rev Biochem"},{"issue":"3","key":"10.1016\/j.bmc.2021.116550_b0020","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0022-2836(78)90368-6","article-title":"Structure of prealbumin: secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8 A","volume":"121","author":"Blake","year":"1978","journal-title":"J Mol Biol"},{"issue":"5213","key":"10.1016\/j.bmc.2021.116550_b0025","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1126\/science.7754382","article-title":"Structure of a complex of two plasma proteins: transthyretin and retinol-binding protein","volume":"268","author":"Monaco","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.bmc.2021.116550_b0030","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0065-3233(08)60321-6","article-title":"Transthyretin quaternary and tertiary structural changes facilitate misassembly into amyloid","volume":"50","author":"Kelly","year":"1997","journal-title":"Adv Protein Chem"},{"issue":"12","key":"10.1016\/j.bmc.2021.116550_b0035","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1021\/ar020073i","article-title":"Native state kinetic stabilization as a strategy to ameliorate protein misfolding diseases: a focus on the transthyretin amyloidoses","volume":"38","author":"Johnson","year":"2005","journal-title":"Acc Chem Res"},{"issue":"5607","key":"10.1016\/j.bmc.2021.116550_b0040","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1126\/science.1079589","article-title":"Prevention of transthyretin amyloid disease by changing protein misfolding energetics","volume":"299","author":"Hammarstrom","year":"2003","journal-title":"Science"},{"issue":"26","key":"10.1016\/j.bmc.2021.116550_b0045","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1021\/bi800636q","article-title":"Quantification of the thermodynamically linked quaternary and tertiary structural stabilities of transthyretin and its disease-associated variants: the relationship between stability and amyloidosis","volume":"47","author":"Hurshman Babbes","year":"2008","journal-title":"Biochemistry"},{"issue":"7","key":"10.1016\/j.bmc.2021.116550_b0050","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1073\/pnas.87.7.2843","article-title":"Fibril in senile systemic amyloidosis is derived from normal transthyretin","volume":"87","author":"Westermark","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.bmc.2021.116550_b0055","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.sbi.2009.12.009","article-title":"Structure-based design of kinetic stabilizers that ameliorate the transthyretin amyloidoses","volume":"20","author":"Connelly","year":"2010","journal-title":"Curr Opin Struc Biol"},{"issue":"Suppl 4","key":"10.1016\/j.bmc.2021.116550_b0060","doi-asserted-by":"crossref","first-page":"16427","DOI":"10.1073\/pnas.202495199","article-title":"Sequence-dependent denaturation energetics: A major determinant in amyloid disease diversity","volume":"99","author":"Hammarstrom","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"issue":"22","key":"10.1016\/j.bmc.2021.116550_b0065","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.1021\/bi027319b","article-title":"D18G transthyretin is monomeric, aggregation prone, and not detectable in plasma and cerebrospinal fluid: a prescription for central nervous system amyloidosis?","volume":"42","author":"Hammarstrom","year":"2003","journal-title":"Biochemistry"},{"issue":"7","key":"10.1016\/j.bmc.2021.116550_b0070","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1056\/NEJM199702133360703","article-title":"Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans","volume":"336","author":"Jacobson","year":"1997","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.bmc.2021.116550_b0075","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/01.LAB.0000059937.11023.1F","article-title":"Energetic characteristics of the new transthyretin variant A25T may explain its atypical central nervous system pathology","volume":"83","author":"Sekijima","year":"2003","journal-title":"Lab Invest"},{"issue":"1","key":"10.1016\/j.bmc.2021.116550_b0080","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cell.2005.01.018","article-title":"The Biological and Chemical Basis for Tissue Selective Amyloid Disease","volume":"121","author":"Sekijima","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.bmc.2021.116550_b0085","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1021\/ja908562q","article-title":"A Substructure Combination Strategy To Create Potent and Selective Transthyretin Kinetic Stabilizers That Prevent Amyloidogenesis and Cytotoxicity","volume":"132","author":"Choi","year":"2010","journal-title":"J Am Chem Soc"},{"issue":"23","key":"10.1016\/j.bmc.2021.116550_b0090","doi-asserted-by":"crossref","first-page":"5589","DOI":"10.1021\/jm0700159","article-title":"Design of mechanism-based inhibitors of transthyretin amyloidosis: Studies with biphenyl ethers and new structural templates","volume":"50","author":"Gupta","year":"2007","journal-title":"J Med Chem"},{"issue":"2","key":"10.1016\/j.bmc.2021.116550_b0095","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1021\/jm0708735","article-title":"Biochemical and structural evaluation of highly selective 2-arylbenzoxazole-based transthyretin amyloidogenesis inhibitors","volume":"51","author":"Johnson","year":"2008","journal-title":"J Med Chem."},{"issue":"20","key":"10.1016\/j.bmc.2021.116550_b0100","doi-asserted-by":"crossref","first-page":"6348","DOI":"10.1021\/jm800435s","article-title":"Toward optimization of the linker substructure common to transthyretin amyloidogenesis inhibitors using biochemical and structural studies","volume":"51","author":"Johnson","year":"2008","journal-title":"J Med Chem"},{"issue":"4","key":"10.1016\/j.bmc.2021.116550_b0105","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1021\/jm801347s","article-title":"Toward Optimization of the Second Aryl Substructure Common to Transthyretin Amyloidogenesis Inhibitors Using Biochemical and Structural Studies","volume":"52","author":"Johnson","year":"2009","journal-title":"J Med Chem"},{"issue":"5","key":"10.1016\/j.bmc.2021.116550_b0110","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1021\/jm049274d","article-title":"Bisaryloxime Ethers as Potent Inhibitors of Transthyretin Amyloid Fibril Formation","volume":"48","author":"Johnson","year":"2005","journal-title":"J Med Chem"},{"issue":"4","key":"10.1016\/j.bmc.2021.116550_b0115","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/74082","article-title":"Rational design of potent human transthyretin amyloid disease inhibitors","volume":"7","author":"Klabunde","year":"2000","journal-title":"Nat Struct Biol"},{"issue":"80","key":"10.1016\/j.bmc.2021.116550_b0120","doi-asserted-by":"crossref","first-page":"9188","DOI":"10.1039\/c3cc44667k","article-title":"Bifunctional coumarin derivatives that inhibit transthyretin amyloidogenesis and serve as fluorescent transthyretin folding sensors","volume":"49","author":"Myung","year":"2013","journal-title":"Chem Commun"},{"issue":"2","key":"10.1016\/j.bmc.2021.116550_b0125","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1021\/jm010257n","article-title":"Synthesis, structure, and activity of diclofenac analogues as transthyretin amyloid fibril formation inhibitors","volume":"45","author":"Oza","year":"2002","journal-title":"J Med Chem"},{"issue":"22","key":"10.1016\/j.bmc.2021.116550_b0130","doi-asserted-by":"crossref","first-page":"12956","DOI":"10.1073\/pnas.95.22.12956","article-title":"Inhibiting transthyretin conformational changes that lead to amyloid fibril formation","volume":"95","author":"Peterson","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"issue":"18","key":"10.1016\/j.bmc.2021.116550_b0135","doi-asserted-by":"crossref","first-page":"6662","DOI":"10.1021\/ja044351f","article-title":"Potent and Selective Structure-Based Dibenzofuran Inhibitors of Transthyretin Amyloidogenesis: Kinetic Stabilization of the Native State","volume":"127","author":"Petrassi","year":"2005","journal-title":"J Am Chem Soc"},{"issue":"24","key":"10.1016\/j.bmc.2021.116550_b0140","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1002\/anie.200351179","article-title":"Benzoxazoles as transthyretin amyloid fibril inhibitors: synthesis, evaluation, and mechanism of action","volume":"42","author":"Razavi","year":"2003","journal-title":"Angew Chem Int Ed Engl"},{"issue":"4","key":"10.1016\/j.bmc.2021.116550_b0145","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nrd769","article-title":"Therapeutic strategies for human amyloid diseases","volume":"1","author":"Sacchettini","year":"2002","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmc.2021.116550_b0150","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.ejmech.2016.02.074","article-title":"A novel bis-furan scaffold for transthyretin stabilization and amyloid inhibition","volume":"121","author":"Simoes","year":"2016","journal-title":"Eur J Med Chem"},{"issue":"2","key":"10.1016\/j.bmc.2021.116550_b0155","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nchembio.281","article-title":"Chemoselective small molecules that covalently modify one lysine in a non-enzyme protein in plasma","volume":"6","author":"Choi","year":"2010","journal-title":"Nat Chem Biol"},{"issue":"1","key":"10.1016\/j.bmc.2021.116550_b0160","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/cmdc.200900356","article-title":"Synthesis, enzymatic evaluation, and docking studies of fluorogenic caspase 8 tetrapeptide substrates","volume":"5","author":"Reszka","year":"2010","journal-title":"ChemMedChem"},{"issue":"4","key":"10.1016\/j.bmc.2021.116550_b0165","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1021\/acs.jmedchem.5b01719","article-title":"Structure-Based Identification of Inhibitory Fragments Targeting the p300\/CBP-Associated Factor Bromodomain","volume":"59","author":"Chaikuad","year":"2016","journal-title":"J Med Chem"},{"issue":"20","key":"10.1016\/j.bmc.2021.116550_b0170","doi-asserted-by":"crossref","first-page":"6470","DOI":"10.1021\/bi952501g","article-title":"The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid","volume":"35","author":"Lai","year":"1996","journal-title":"Biochemistry"},{"issue":"24","key":"10.1016\/j.bmc.2021.116550_b0175","doi-asserted-by":"crossref","first-page":"9629","DOI":"10.1073\/pnas.1121005109","article-title":"Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade","volume":"109","author":"Bulawa","year":"2012","journal-title":"P Natl Acad Sci USA"},{"issue":"16","key":"10.1016\/j.bmc.2021.116550_b0180","doi-asserted-by":"crossref","first-page":"6507","DOI":"10.1021\/acs.jmedchem.5b00544","article-title":"Enthalpic Forces Correlate with the Selectivity of Transthyretin-Stabilizing Ligands in Human Plasma","volume":"58","author":"Iakovleva","year":"2015","journal-title":"J Med Chem"},{"issue":"70","key":"10.1016\/j.bmc.2021.116550_b0185","doi-asserted-by":"crossref","first-page":"10424","DOI":"10.1039\/C9CC04172A","article-title":"A highly sensitive fluorescent probe that quantifies transthyretin in human plasma as an early diagnostic tool of Alzheimer's disease","volume":"55","author":"Lim","year":"2019","journal-title":"Chem Commun (Camb)"},{"issue":"Pt 4","key":"10.1016\/j.bmc.2021.116550_b0190","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1107\/S0907444996003046","article-title":"Structures of human transthyretin complexed with thyroxine at 2.0 A resolution and 3',5'-dinitro-N-acetyl-L-thyronine at 2.2 A resolution","volume":"52","author":"Wojtczak","year":"1996","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"issue":"2\u20133","key":"10.1016\/j.bmc.2021.116550_b0195","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/minf.201000126","article-title":"Discovery of a Potent and Selective Hetero-Bivalent AChE Inhibitor via Bioisosteric Replacement","volume":"30","author":"Nicolotti","year":"2011","journal-title":"Mol Inform"},{"issue":"41","key":"10.1016\/j.bmc.2021.116550_b0200","doi-asserted-by":"crossref","first-page":"13560","DOI":"10.1021\/bi991021c","article-title":"The most pathogenic transthyretin variant, L55P, forms amyloid fibrils under acidic conditions and protofilaments under physiological conditions","volume":"38","author":"Lashuel","year":"1999","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/j.bmc.2021.116550_b0205","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/jcc.540040211","article-title":"CHARMM: A program for macromolecular energy, minimization, and dynamics calculations","volume":"4","author":"Brooks","year":"1983","journal-title":"J Comput Chem"},{"issue":"2","key":"10.1016\/j.bmc.2021.116550_b0210","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/1097-0134(20010501)43:2<113::AID-PROT1023>3.0.CO;2-T","article-title":"High throughput docking for library design and library prioritization","volume":"43","author":"Diller","year":"2001","journal-title":"Proteins"}],"container-title":["Bioorganic &amp; Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089621005587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089621005587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:16:30Z","timestamp":1760836590000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089621005587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":42,"alternative-id":["S0968089621005587"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2021.116550","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and biological evaluation of quinolone derivatives as transthyretin amyloidogenesis inhibitors and fluorescence sensors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2021.116550","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116550"}}